{
    "Trade/Device Name(s)": [
        "LZI Amphetamines 500 Enzyme Immunoassay",
        "LZI Amphetamines 500 Drugs of Abuse (DAU) Calibrators",
        "LZI Amphetamines 500 Drugs of Abuse (DAU) Controls"
    ],
    "Submitter Information": "Lin-Zhi International, Inc.",
    "510(k) Number": "K102210",
    "Predicate Device Reference 510(k) Number(s)": [
        "K020395"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKZ",
        "DJC",
        "DLJ",
        "LAS"
    ],
    "Summary Letter Date": "December 17, 2010",
    "Summary Letter Received Date": "December 17, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.3100",
        "21CFR862.3610",
        "21CFR862.3200",
        "21CFR862.3280"
    ],
    "Regulation Name(s)": [
        "Amphetamine test system",
        "Thin layer chromatography, methamphetamine",
        "Amphetamines calibrators",
        "Amphetamines controls"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "d-methamphetamine",
        "d-amphetamine"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Hitachi 717 automated clinical system analyzer",
        "automated clinical chemistry analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous enzyme immunoassay",
        "Enzyme immunoassay (EIA)"
    ],
    "Methodologies": [
        "Immunoassay",
        "Competitive binding",
        "Enzyme activity measurement"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for LZI Amphetamines 500 Enzyme Immunoassay, calibrators, and controls for qualitative and semi-quantitative detection of amphetamine and methamphetamine in urine",
    "Indications for Use Summary": "Intended for the qualitative and semi-quantitative determination of amphetamine and methamphetamine in human urine at a cutoff of 500 ng/mL, for professional use with automated clinical chemistry analyzers; calibrators and controls support assay calibration and precision monitoring",
    "fda_folder": "Toxicology"
}